Diasome presents HDV-Insulin Phase 2b clinical results with new hypoglycemia data at the Breakthrough T1D Clinical & Research Congress

CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”